Bender James G.
VP, Product Development & Mfg. at ImmunoCellular Therapeutics, Ltd.
- Sold, on record
- $93k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Aug 29, 2013
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ImmunoCellular Therapeutics, Ltd.VP, Product Development & Mfg.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale ImmunoCellular Therapeutics, Ltd.UnusualMay 31, 2012 2012
Sold 7,000 shares at $3.92 ($27k)
Bender James G., VP, Product Development & Mfg.
Sold 47.7% of holdings ($58k position)7,679 shares leftFirst sale on recordFiling
- 2 Form 4 sale ImmunoCellular Therapeutics, Ltd.UnusualJun 1, 2012 +1 day
Sold 7,000 shares at $3.60 ($25k)
Bender James G., VP Product Development & Mfg.
Sold 88.8% of holdings ($28k position)879 shares leftFiling
- 3 Form 4 sale ImmunoCellular Therapeutics, Ltd.UnusualAug 29, 2013 +454 days
Sold 14,203 shares at $2.87 ($41k)
Bender James G., VP, Product Development & Mfg.
Sold 99.3% of holdings ($41k position)100 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2013 | Aug 30, 2013 | ImmunoCellular Therapeutics, Ltd. | VP, Product Development & Mfg. | Form 4 sale | 14,203 | $41k | 99.3% | Unusual | SEC |
| Jun 1, 2012 | Jun 6, 2012 | ImmunoCellular Therapeutics, Ltd. | VP Product Development & Mfg. | Form 4 sale | 7,000 | $25k | 88.8% | Unusual | SEC |
| May 31, 2012 | May 31, 2012 | ImmunoCellular Therapeutics, Ltd. | VP, Product Development & Mfg. | Form 4 sale | 7,000 | $27k | 47.7% | Unusual | SEC |